Abstract:Emerging evidence suggests that accumulation of oxidative DNA damage in nuclear genome is an important contributing factor in neuronal cell death after cerebral ischemia. It has been shown in various models of cerebral ischemia/reperfusion that there is accumulation of oxidative DNA base damage and apurinic/apyridinic abasic site (AP site) in injured neurons, which could mediate neuronal degeneration by triggering various pro-apoptotic molecules. In the brain most types of oxidative DNA damage are repaired via the base-excision repair (BER) pathway that is highly inducible in response to various sublethal stimuli. Thus, interventions that enhance the activity of the BER pathway may be a potential therapeutic strategy against ischemic cell death. In the present study, we have examined the neuroprotective effect of the neuropeptide pituitary adenylate cyclase activating polypeptide (PACAP) in the rat model of transient global cerebral ischemia. Further, we have investigated the role of BER regulation as a potential mechanism underlying the effect of PACAP. PACAP, when infused intracerebroventricularly in the rat, potently protected against CA1 neuronal cell death after global cerebral ischemia produced by 12 minutes of 4-vessel occlusion. Associated with this neuroprotection, PACAP treatment reduced the accumulation of oxidative DNA lesions, especially AP site, and subsequently attenuated the activation of pro-apoptotic molecules p53 and PUMA in the CA1 sector, suggesting that the effect of PACAP may involve the acceleration of the repair process of endogenous oxidative DNA damage. To investigate the underlying mechanism, cellular BER activity and the expression of BER enzymes were measured in the hippocampal extracts. The results revealed that PACAP markedly enhanced the hippocampal expression (at both mRNA and protein levels) and activities of the essential BER enzymes AP endonuclase (APE) and DNA polymerase-beta. Furthermore, based on the results of inhibition studies, the inducible effect of PACAP on the BER pathway was found to be dependent on the phosphorylation and nuclear translocation of cAMP-response-element-binding protein (CREB), which mediated the enhanced transcription of both APE and DNA polymerase-beta. Finally, the effect of PACAP on BER and neuroprotection was mimicked by the administration of a cAMP/protein kinase A (PKA) agonist. The results of the present study demonstrate the neuroprotective effect of PACAP in hippocampal CA1 neurons after transient global cerebral ischemia. The effect of PACAP is dependent on the activation and nuclear translocation of CREB, and involves CREB-mediated activation of BER pathway for endogenous DNA repair. The results suggest that enhancement of neuronal DNA repair capacity by PACAP or other means may be a novel potential therapeutic approach to limit ischemic neuronal loss. (This project was supported by NIH grants NS36736, NS38560, NS 43802, and NS45048).

PACAP Attenuates Optic Nerve Crush-Induced Retinal Ganglion Cell Apoptosis Via Activation of the CREB-Bcl-2 Pathway

Protective Effects of Pituitary Adenylate-Cyclase-Activating Polypeptide on Retinal Vasculature and Molecular Responses in a Rat Model of Moderate Glaucoma

Neuroprotection of a Novel Cyclopeptide CHSDGIC from the Cyclization of PACAP (1-5) in Cellular and Rodent Models of Retinal Ganglion Cell Apoptosis.

Effects of Cyclopeptide CHSDGIC from the Cyclization of PACAP (1–5) on the Proliferation and UVB-induced Apoptosis of the Retinal Ganglion Cell Line RGC-5

PACAP protects cerebellar granule neurons against oxidative stress-induced apoptosis

PACAP-derived Mutant Peptide MPAPO Protects Trigeminal Ganglion Cell and the Retina from Hypoxic Injury Through Anti-Oxidative Stress, Anti-Apoptosis, and Promoting Axon Regeneration.

Rapamycin Attenuates Retinal Ganglion Cell Death by Inhibiting Pyroptosis Induced by Optic Nerve Crush

Rapamycin suppresses neuroinflammation and protects retinal ganglion cell loss after optic nerve crush

Pituitary Adenylate Cyclase Activating Polypeptide Elicits Neuroprotection Against Acute Ischemic Neuronal Cell Death Associated with NMDA Receptors

Exosome-Mediated Delivery of the Neuroprotective Peptide PACAP38 Promotes Retinal Ganglion Cell Survival and Axon Regeneration in Rats with Traumatic Optic Neuropathy

Neuroprotection against ischemic CA1 neurodegeneration by pituitary adenylate cyclase activating polypeptide via cAMP-response-element-binding protein-mediated enhancement of endogenous DNA repair

Effects of Pituitary Adenylate Cyclase Activating Polypeptide and Its Fragments on Retinal Degeneration Induced by Neonatal Monosodium Glutamate Treatment

Protective Effect of Total Panax Notoginseng Saponins on Retinal Ganglion Cells of an Optic Nerve Crush Injury Rat Model

Retinal glial responses to optic nerve crush are attenuated in Bax-deficient mice and modulated by purinergic signaling pathways

Activation of Autophagy and Paraptosis in Retinal Ganglion Cells after Retinal Ischemia and Reperfusion Injury in Rats

Pituitary adenylate cyclase-activating polypeptide attenuates mitochondria-mediated oxidative stress and neuronal apoptosis after subarachnoid hemorrhage in rats

Early phosphoproteomic changes in the retina following optic nerve crush

PACAP protects neuronal differentiated PC12 cells against the neurotoxicity induced by a mitochondrial complex I inhibitor, rotenone.

PACAP glycosides promote cell outgrowth in vitro and reduce infarct size after stroke in a preclinical model

Injectable Gel-PEG hydrogels as promising delivery system for intravitreal PACAP release: Novel therapeutics for unilateral common carotid artery occlusion induced retinal ischemia

Protection of Pattern Electroretinogram and Retinal Ganglion Cells by Oncostatin M after Optic Nerve Injury